GnRH agonist and prasterone/acolbifeneAlternative Names: Femitra
Latest Information Update: 02 Dec 2015
At a glance
- Originator Endoceutics
- Class Hormonal replacements; Small molecules; Testosterone congeners
- Mechanism of Action Gonadotropin releasing hormone stimulants; Selective estrogen receptor modulators; Testosterone replacements
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Phase III Endometriosis
Most Recent Events
- 02 Dec 2015 Phase-III development for Endometriosis is ongoing in Canada